Precision Medicine-Based Platform to Guide the Treatment of EML4-ALK Lung Cancers and Other Non-Small Cell Lung Cancers

Author:

Merrill Nathan1,Udager Aaron1,Qin Angel1,Lagisetty Kiran1,Aikins Marisa1,Bao Liwei1,Cheng Xu1,Goo Layra1,Kathawate Varun1,Vandenburg Bryce1,Ulintz Peter1,Qin Zhaoping1,Liu Chia-Jen1,Serhan Habib1,Nagrath Sunitha1,Hsu Peggy1,Soellner Matthew1,Merajver Sofia1

Affiliation:

1. University of Michigan, Ann Arbor, USA

Publisher

European Medical Group

Subject

General Medicine

Reference5 articles.

1. Barta JA et al. Global epidemiology of lung cancer. Ann Glob Health. 2019;85(1):8.

2. Dubin S, Griffin D. Lung cancer in non-smokers. Mo Med. 2020;117(4):375-9.

3. Vašíková A. [EML4-ALK fusion gene in patients with lung carcinoma: biology, diagnostics and targeted therapy]. Klin Onkol. 2012;25(6):434-9. (In Czech).

4. Tabbò F et al. Resistance to anaplastic lymphoma kinase inhibitors: knowing the enemy is half the battle won. Transl Lung Cancer Res. 2020;9(6):2545-56.

5. Merrill NM et al. MEK is a promising target in the basal subtype of bladder cancer. Oncotarget. 2020;11(44):3921-32.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3